# | Name | Compound Key | Action Type | Relation | Activity Value | Units | Assay ID | Assay Description | Comment | Assay | Assay Organism | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | Elacridar | 84 | % maximum response | = | 100 | % | ALA1908292 | Calcein-AM Inhibitor: Y | % | Homo sapiens | ||
2. | Elacridar | 84 | Ratio_ATPase activity | = | 0.23 | ALA1908291 | ATPase Activator: N | Homo sapiens | ||||
3. | Elacridar | 84 | Ratio_Papp | 0 | ALA1908289 | Effluxed: N | Homo sapiens | |||||
4. | Elacridar | 84 | Papp | = | 18.6 | nm/s | ALA1908286 | nm/s | Homo sapiens | |||
5. | Elacridar | 84 | Papp | = | 2.12 | nm/s | ALA1908285 | nm/s | Homo sapiens | |||
6. | Elacridar | 84 | INH | 0 | ALA3537087 | Active | % | Homo sapiens | ||||
7. | Elacridar | 84 | INH | 0 | ALA3537086 | Active | % | |||||
8. | Elacridar | 84 | PPB | 98.21 | % | ALA3301366 | % | |||||
9. | Elacridar | 84 | inhibition | = | -0.09 | % | ALA4513082 | % | Severe acute respiratory syndrome coronavirus 2 | |||
10. | Elacridar | 84 | Inhibition | = | -8.367 | % | ALA4495582 | % | Severe acute respiratory syndrome coronavirus 2 | |||
11. | Elacridar | 84 | Papp | = | 17 | 10'-6 cm/s | ALA4429294 | 10'-6 cm/s | ||||
12. | Elacridar | 84 | INH | = | 94.4 | % | ALA2169429 | % | Homo sapiens | |||
13. | Elacridar | 84 | INH | = | 37.4 | % | ALA2169430 | % | Homo sapiens | |||
14. | Elacridar | 84 | INH | = | 67.2 | % | ALA2169431 | % | Homo sapiens | |||
15. | Elacridar | 84 | Potency | 18.655 | uM | ALA3562002 | active | nM | ||||
16. | Elacridar | 84 | Potency | 5.258 | uM | ALA3562018 | active | nM | ||||
17. | Elacridar | 84 | Potency | 18.655 | uM | ALA3562067 | active | nM | ||||
18. | Elacridar | 84 | Potency | 18.655 | uM | ALA3215154 | active | nM | ||||
19. | Elacridar | 84 | Potency | 16.626 | uM | ALA3214997 | active | nM | ||||
20. | Elacridar | 84 | Potency | 1.541 | uM | ALA3215013 | inactive | nM | Homo sapiens |